0 Comentários
0 Compartilhamentos
16 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Multiplex PCR Panel Testing Market Expansion Through Precision Medicine ApplicationsThe global Multiplex PCR Panel Testing Market size was estimated at USD 2.58 billion in 2025 and is projected to reach USD 4.86 billion by 2033, registering a CAGR of 8.42% from 2026 to 2033. The market is expanding steadily due to the increasing prevalence of respiratory and gastrointestinal infections, rising adoption of rapid syndromic testing, and growing demand for accurate...0 Comentários 0 Compartilhamentos 465 Visualizações 0 Anterior
-
AI In Radiology Market and the Future of Precision MedicineThe global AI In Radiology Market is experiencing unprecedented growth as healthcare systems worldwide increasingly adopt artificial intelligence to improve diagnostic accuracy, streamline workflows, and enhance patient outcomes. The market size was valued at USD 14.6 billion in 2025 and is projected to reach USD 193.0 billion by 2033, expanding at an exceptional CAGR of 38.2% from...0 Comentários 0 Compartilhamentos 701 Visualizações 0 Anterior
-
[ Latest Report ] Non-Oncology Precision Medicine Market Share, Growth by Business Developments 2025 to 2032Non-Oncology Precision Medicine Market Summary “The global Non-Oncology Precision Medicine Market is expected to reach to USD 57.3 billion by 2032, growing at a CAGR of 5.7% during 2025 to 2032” The TrendBridge Insights Research report, “Global Non-Oncology Precision Medicine Market Report 2025 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Rare Disease Genetic Testing Market Industry Overview and Growth AnalysisThe global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...0 Comentários 0 Compartilhamentos 44 Visualizações 0 Anterior